Measurement of the Performance and Safety of RTR+Membrane in Guided Tissue Regeneration (GTR) in Dental Surgical Procedures
ObsR+
Prospective, National, Multicentre and Observational Clinical Investigation of R.T.R.+ Membrane Used in Guided Tissue Regeneration (GTR) in Dental Surgical Procedures
1 other identifier
observational
90
1 country
9
Brief Summary
The goal of this observational study is to measure in real practice the performance and safety of RTR+Membrane, a synthetic dental membrane for guided tissue regeneration in periodontal or dental implant surgery. The main question it aims to answer is to measure the post-operative wound healing several months after surgery. Participants will be followed after their dental surgery via clinical examination and radiological and photos images.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2024
Typical duration for all trials
9 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 2, 2024
CompletedStudy Start
First participant enrolled
February 9, 2024
CompletedFirst Posted
Study publicly available on registry
June 21, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2026
CompletedMay 1, 2026
April 1, 2026
2.2 years
January 2, 2024
April 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Post-operative wound healing measured by the Early Wound-Healing Index
For all groups The Early Wound-Healing Index (EHI) has the following best to worst scoring: (EHI) 1: complete flap closure without fibrin line in the interproximal area. (EHI) 2: complete flap closure with fine fibrin line in the interproximal area. (EHI) 3: complete flap closure with fibrin clot in the interproximal area. (EHI) 4: incomplete flap closure with partial necrosis of the interproximal tissue. (EHI) 5: incomplete flap closure with complete necrosis of the interproximal tissue. The EHI is evaluated at the Visit 3 (late post-surgery follow-up) for the primary outcome measure.
up to 6 months
Secondary Outcomes (7)
Post-operative wound healing measured by Early Wound-Healing Index
up to 14 days
Post-operative wound healing measured by Early Wound Healing Score
up to 14 days
Post-operative clinical exam
up to 6 months
Number of adverse device effects (at least possibly) related to study device
up to 6 months
Oral Health-Related Quality of Life measured by the Oral Health Impact Profile (OHIP-5 items)
up to 6 months
- +2 more secondary outcomes
Study Arms (3)
Post-extraction socket preservation group
The 30 eligible patients are any male and female, adult patients with the following dental treatment to be done with the study device: Post-extraction socket preservation (not done concomitantly to implant placement).
Alveolar ridge augmentation group
The 30 eligible patients are any male and female, adult patients with the following dental treatment to be done with the study device: Alveolar ridge augmentation (not done concomitantly to implant placement).
Guided Tissue Regeneration (GTR) during immediate implant placement group
The 30 eligible patients are any male and female, adult patients with the following dental treatment to be done with the study device: Guided Tissue Regeneration (GTR) during immediate implant placement
Interventions
* Visit 1: A periodontal or dental implant surgery is done aiming to preserve alveolar bone volume after extraction * Visit 2 (10 days ± 4 days) - Early post-surgery follow-up * V2bis (1 month +/- 1 week) - Early post-surgery follow-up * Visit 3 (5 months ± 1 month) - Late post-surgery follow-up
* Visit 1: A periodontal or dental implant surgery is done aiming to alveolar crest reconstruction * Visit 2 (10 days ± 4 days) - Early post-surgery follow-up * Visit 3 (5 months ± 1 month) - Late post-surgery follow-up
* Visit 1: A periodontal or dental implant surgery is done aiming to cover bone defects during immediate implant placement. * Visit 2 (10 days ± 4 days) - Early post-surgery follow-up * Visit 3 (3 months ± 1 month) - Late post-surgery follow-up
Eligibility Criteria
Eligible patients are any male and female, adult patients with one of the 3 following dental treatments to be done with the study device: * post-extraction socket preservation\*, * alveolar ridge augmentation\*, * Guided Tissue Regeneration (GTR) during immediate implant placement. The dental treatment under investigation for one patient could be related to: * 1 alveolar socket corresponding to only 1 tooth; * 1 implant to be placed in replacement of 1 tooth; * several contiguous alveolar sockets; * Or, several contiguous implants to be placed. Dental treatments done simultaneously in non-contiguous dental zones won't be considered for this study.
You may qualify if:
- Male or female adult patient
- Patient with one of the 3 following dental treatments to be done with the study device: post-extraction socket preservation, alveolar ridge augmentation, or Guided Tissue Regeneration (GTR) during immediate implant placement.
- Patient affiliated or beneficiary of a social security system.
- Patient has signed his/her informed consent form.
You may not qualify if:
- Pregnancy or lactation
- Active tissue infection at the implant site
- Several dental treatments done simultaneously in non-contiguous dental zones
- Heavy smoker (\>10 cigarettes / day)
- Patient receiving long-term corticosteroid therapy, anti-rejection drugs, bisphosphonates, head \& neck radiotherapy or chemotherapy
- Patient with chronic infections (such as osteomyelitis) at the surgical site
- Patient with poorly controlled metabolic disorders (such as diabetes, osteomalacia, thyroid disorders)
- Patient with an auto-immune disease
- Patient under tutelage, vulnerable person, person without liberty, or unable to complete questionnaire independently
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Septodontlead
Study Sites (9)
Hospital University of Nantes
Nantes, 44000, France
Private dental practice office of Dr. Alain Hoornaert
Nantes, 44000, France
Private dental practice office of Dr. Samer Saloum-Rouxel
Nantes, 44000, France
Private dental practice office of Dr. Xavier Struillou
Nantes, 44000, France
Private dental practice office of Dr. Edouard Lanoiselée
Nozay, 44170, France
Private dental practice office of Dr. Aurélien Fruchet
Olonne-sur-Mer, 85340, France
Private dental practice office of Dr. Hélène Le Hécho
Orée d'Anjou, 49530, France
Private dental practice office of Dr. Nicolas Strube
Orvault, 44700, France
Private dental practice office of Dr. Romain Besnier
Orvault, 44700, France
Study Officials
- PRINCIPAL INVESTIGATOR
Alain Hoornaert, DDS
University Hospital of Nantes
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 2, 2024
First Posted
June 21, 2024
Study Start
February 9, 2024
Primary Completion
May 1, 2026
Study Completion
May 1, 2026
Last Updated
May 1, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share